Loading...

Akili, Inc.

AKLINASDAQ
Healthcare
Medical - Healthcare Information Services
$0.43
$0.001(0.25%)

Akili, Inc. (AKLI) Stock Overview

Explore Akili, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.9/100

Key Financials

Market Cap34.1M
P/E Ratio-0.57
EPS (TTM)$-0.61
ROE-0.70%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.12

AKLI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Akili, Inc. (AKLI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.12.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.57 and a market capitalization of 34.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.37%
3-Month Change
8.28%
6-Month Change
72.48%
Year-to-Date (YTD) Change
-9.34%
1-Year Change
-63.61%
3-Year Change
-95.60%
5-Year Change
-95.72%
All-Time (Max) Change
-95.72%

Contact Information

617-456-0597
125 Broad Street, Boston, MA, 02110

Company Facts

68 Employees
IPO DateJun 30, 2021
CountryUS

Frequently Asked Questions

;